Skip to content

Trial evaluating effectiveness of quadratus lumborum block which is a method of providing postoperative analgesia, in patients undergoing percutaneous nephrolithotomy, which is a surgical procedure for removal of kidney stones.

Quadratus lumborum block for patients undergoing percutaneous nephrolithotomy: a randomized controlled study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2017/04/008300
Enrollment
40
Registered
2017-04-06
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N200- Calculus of kidney Health Condition 2: null- Nephrolithiasis

Interventions

Intervention1: Group QL(Quadratus lumborum block group): Patients in this group will be administered quadratus lumborum block with ropivacaine after neuraxial anesthesia, before start of surgery Contr

Sponsors

Dr Rajesh Raman
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: American Society of Anaesthesiologists grade I to III patients scheduled for percutaneous nephrolithotomy under spinal anesthesia

Exclusion criteria

Exclusion criteria: Patient refusal to give consent, local site infection, allergy to study medications, coagulopathy or patient on anticoagulants

Design outcomes

Primary

MeasureTime frame
Time taken for first analgesic request by patient after end of surgeryTimepoint: post operative period, whenever patient demands first analgesic dose. The time difference from end of surgery to request of analgesic first time for pain in postoperative period.

Secondary

MeasureTime frame
Postoperative pain at rest and at movement on Visual analogue score, total analgesic consumption in 24 hours, patient satisfaction and side effectsTimepoint: Pain scores(at rest and on movement) will be assessed in post operative period every 2 hours.Patient satisfaction and Total analgesic consumption will be assessed at 24 hours from end of surgery. Side effects in first 24 hours will be recorded.

Countries

India

Contacts

Public ContactRajesh Raman

King Georges Medical University, Lucknow

ramanrajesh83@gmail.com9451564339

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026